Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Lower doses may not achieve the same blood sugar or weight loss outcomes as full therapeutic levels
How is Tirzepatide taken
Comparable GH release to GHRP-6 without the cortisol, prolactin, or appetite effects
Market Segmentation Short-acting Long-acting Dual-action Type 2 Diabetes Obesity Cardiovascular Diseases Subcutaneous Injection Oral Inhalation Hospital Pharmacies Retail Pharmacies Online Pharmacies Report Scope FAQs The GLP-1 Drug Market was valued at 10.77 USD Billion in 2024
Tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, not a pure GLP-1 agent
US$ 20.29
US$ 26.18
US$ 20.71
US$ 24.05
US$ 28.11
US$ 24.74
US$ 22.42
